✦ LIBER ✦

Pharmacological protein targets in polyglutamine diseases: Mutant polypeptides and their interactors

✍ Scribed by Margulis, Boris A.; Vigont, Vladimir; Lazarev, Vladimir F.; Kaznacheyeva, Elena V.; Guzhova, Irina V.

Book ID: 120405573
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 742 KB
Volume: 587
Category: Article
ISSN: 0014-5793
DOI: 10.1016/j.febslet.2013.05.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteoglycans in health and disease: nov

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

✍ Achilleas D. Theocharis; Spyridon S. Skandalis; George N. Tzanakakis; Nikos K. K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Monoclonal antibodies and fusion protein

Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases

✍ Lee, Susan; Ballow, Mark 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 329 KB

[Handbook of Experimental Pharmacology]

[Handbook of Experimental Pharmacology] Protein-Protein Interactions as New Drug Targets Volume 186 || Role of Ena/VASP Proteins in Homeostasis and Disease

✍ Klussmann, Enno; Scott, John 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg ⚖ 161 KB

A mutant precursor protein is poorly tar

A mutant precursor protein is poorly targeted to mitochondria and interferes in vivo with the import of other mitochondrial polypeptides inSaccharomyces cerevisiae

✍ Eulogio Valentin; Michelle E. Walker; Graeme A. Reid 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 917 KB

Mice with targeted disruption of neurofi

Mice with targeted disruption of neurofilament light subunit display formation of protein aggregation in motoneurons and downregulation of complement receptor type 3 α subunit in microglia in the spinal cord at their earlier age: A possible feature in pre-clinical development of neurodegenerative diseases

✍ Zhao Hui Li; Jia Lu; Samuel Sam Wah Tay; Ya Jun Wu; Michael Joseph Strong; Bei P 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Books of Interest Emerging Drugs and Tar

Books of Interest Emerging Drugs and Targets for Alzheimer’s Disease. Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 317 pp. 16 × 24 cm. ISBN 978-1-84973-063-1 . $249.00. Emerging Drugs and Targets for Alzheimer’s Disease. Volume 2: Neuronal Plasticity, Neuronal Protection and Other Miscellaneous Strategies . Edited by Ana Martinez Royal Society of Chemistry , Cambridge, U.K. 2010 . xxiv + 301 pp. 16 × 24 cm. ISBN 978-1-84973-064-8 . $249.00. Biopharmaceuticals in Plants. Toward the Next Century of Medicine . By Kathleen Laura Hefferon CRC Press , Boca Raton, FL . 2010 . xvii + 206 pp. 16 × 24 cm. ISBN 13 978-1-4398-0474-2 . $99.95. GPCR Molecular Pharmacology and Drug Targeting . Edited by Annette Gilchrist Wiley , Hoboken, NJ . 2010 . xxi + 520 pp. 16 × 24 cm. ISBN 978-0-470-30778-6 . $149.95. Drug Development Perspectives. Considerations, Challenges, and Strategies . Edited by Nuggehally R. Srinivas HNB Publishing , New York, NY . 2010 . x + 326 pp. 16 × 24 cm. ISBN 978-0-9664286-9-8 . $99.75. Chemoinformatics and Computational Chemical Biology . Edited by Jürgen Bajorath Humana Press/Springer Science , New York, NY . 2010 . x + 588 pp. 18.5 × 26 cm. ISBN 978-1-60761-838-6 . $159.00. Functional Molecules from Natural Sources . Edited by Stephen K. Wrigley , Robert Thomas , Colin T. Bedford , and Neville Nicholson Royal Society of Chemistry , Cambridge, U.K. 2011 . x + 233 pp. 16 × 24 cm. ISBN 978-1-84755-259-4 . £109.99.

📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 606 KB